Cargando…

Bronchiectasis Information and Education: a randomised, controlled feasibility trial

BACKGROUND: There has been comparatively little patient information about bronchiectasis, a chronic lung disease with rising prevalence. Patients want more information, which could improve their understanding and self-management. A novel information resource meeting identified needs has been co-deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hester, Katy L. M., Ryan, Vicky, Newton, Julia, Rapley, Tim, De Soyza, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158127/
https://www.ncbi.nlm.nih.gov/pubmed/32293509
http://dx.doi.org/10.1186/s13063-020-4134-5
_version_ 1783522475964891136
author Hester, Katy L. M.
Ryan, Vicky
Newton, Julia
Rapley, Tim
De Soyza, Anthony
author_facet Hester, Katy L. M.
Ryan, Vicky
Newton, Julia
Rapley, Tim
De Soyza, Anthony
author_sort Hester, Katy L. M.
collection PubMed
description BACKGROUND: There has been comparatively little patient information about bronchiectasis, a chronic lung disease with rising prevalence. Patients want more information, which could improve their understanding and self-management. A novel information resource meeting identified needs has been co-developed in prior work. We sought to establish the feasibility of conducting a multi-centre randomised controlled trial to determine effect of the information resource on understanding, self-management and health outcomes. METHODS/DESIGN: We conducted an unblinded, single-centre, randomised controlled feasibility trial with two parallel groups (1:1 ratio), comparing a novel patient information resource with usual care in adults with bronchiectasis. Integrated qualitative methods allowed further evaluation of the intervention and trial process. The setting was two teaching hospitals in North East England. Participants randomised to the intervention group received the information resource (website and booklet) and instructions on its use. Feasibility outcome measures included willingness to enter the trial, in addition to recruitment and retention rates. Secondary outcome measures (resource use and satisfaction, quality of life, unscheduled healthcare presentations, exacerbation frequency, bronchiectasis knowledge and lung function) were recorded at baseline, 2 weeks and 12 weeks. RESULTS: Sixty-two participants were randomised (control group = 30; intervention group = 32). Thirty-eight (61%) were female, and the participants’ median age was 65 years (range 15–81). Median forced expiratory volume in 1 s percent predicted was 68% (range 10–120). Sixty-two of 124 (50%; 95% CI, 41–59%) of potentially eligible participants approached were recruited. Sixty (97%) of 62 participants completed the study (control group, 29 of 30 [97%]; 95% CI, 83–99%; 1 unrelated death; intervention group, 31 [97%] of 32; 95% CI, 84–99%; 1 withdrawal). In the intervention group, 27 (84%) of 32 reported using the information provided, and 25 (93%) of 27 of users found it useful, particularly the video content. Qualitative data analysis revealed acceptability of the trial and intervention. Web analytics recorded over 20,000 page views during the 16-month study period. CONCLUSION: The successful recruitment process, high retention rate and study form completion rates indicate that it appears feasible to conduct a full trial based on this study design. Worldwide demand for online access to the information resource was high. TRIAL REGISTRATION: ISRCTN Registry, ISRCTN84229105. Registered on 25 July 2014.
format Online
Article
Text
id pubmed-7158127
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71581272020-04-21 Bronchiectasis Information and Education: a randomised, controlled feasibility trial Hester, Katy L. M. Ryan, Vicky Newton, Julia Rapley, Tim De Soyza, Anthony Trials Research BACKGROUND: There has been comparatively little patient information about bronchiectasis, a chronic lung disease with rising prevalence. Patients want more information, which could improve their understanding and self-management. A novel information resource meeting identified needs has been co-developed in prior work. We sought to establish the feasibility of conducting a multi-centre randomised controlled trial to determine effect of the information resource on understanding, self-management and health outcomes. METHODS/DESIGN: We conducted an unblinded, single-centre, randomised controlled feasibility trial with two parallel groups (1:1 ratio), comparing a novel patient information resource with usual care in adults with bronchiectasis. Integrated qualitative methods allowed further evaluation of the intervention and trial process. The setting was two teaching hospitals in North East England. Participants randomised to the intervention group received the information resource (website and booklet) and instructions on its use. Feasibility outcome measures included willingness to enter the trial, in addition to recruitment and retention rates. Secondary outcome measures (resource use and satisfaction, quality of life, unscheduled healthcare presentations, exacerbation frequency, bronchiectasis knowledge and lung function) were recorded at baseline, 2 weeks and 12 weeks. RESULTS: Sixty-two participants were randomised (control group = 30; intervention group = 32). Thirty-eight (61%) were female, and the participants’ median age was 65 years (range 15–81). Median forced expiratory volume in 1 s percent predicted was 68% (range 10–120). Sixty-two of 124 (50%; 95% CI, 41–59%) of potentially eligible participants approached were recruited. Sixty (97%) of 62 participants completed the study (control group, 29 of 30 [97%]; 95% CI, 83–99%; 1 unrelated death; intervention group, 31 [97%] of 32; 95% CI, 84–99%; 1 withdrawal). In the intervention group, 27 (84%) of 32 reported using the information provided, and 25 (93%) of 27 of users found it useful, particularly the video content. Qualitative data analysis revealed acceptability of the trial and intervention. Web analytics recorded over 20,000 page views during the 16-month study period. CONCLUSION: The successful recruitment process, high retention rate and study form completion rates indicate that it appears feasible to conduct a full trial based on this study design. Worldwide demand for online access to the information resource was high. TRIAL REGISTRATION: ISRCTN Registry, ISRCTN84229105. Registered on 25 July 2014. BioMed Central 2020-04-15 /pmc/articles/PMC7158127/ /pubmed/32293509 http://dx.doi.org/10.1186/s13063-020-4134-5 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hester, Katy L. M.
Ryan, Vicky
Newton, Julia
Rapley, Tim
De Soyza, Anthony
Bronchiectasis Information and Education: a randomised, controlled feasibility trial
title Bronchiectasis Information and Education: a randomised, controlled feasibility trial
title_full Bronchiectasis Information and Education: a randomised, controlled feasibility trial
title_fullStr Bronchiectasis Information and Education: a randomised, controlled feasibility trial
title_full_unstemmed Bronchiectasis Information and Education: a randomised, controlled feasibility trial
title_short Bronchiectasis Information and Education: a randomised, controlled feasibility trial
title_sort bronchiectasis information and education: a randomised, controlled feasibility trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158127/
https://www.ncbi.nlm.nih.gov/pubmed/32293509
http://dx.doi.org/10.1186/s13063-020-4134-5
work_keys_str_mv AT hesterkatylm bronchiectasisinformationandeducationarandomisedcontrolledfeasibilitytrial
AT ryanvicky bronchiectasisinformationandeducationarandomisedcontrolledfeasibilitytrial
AT newtonjulia bronchiectasisinformationandeducationarandomisedcontrolledfeasibilitytrial
AT rapleytim bronchiectasisinformationandeducationarandomisedcontrolledfeasibilitytrial
AT desoyzaanthony bronchiectasisinformationandeducationarandomisedcontrolledfeasibilitytrial